Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.

Journal of cancer research and clinical oncology - 1 Nov 2002

Yoshimura Chie, Nomura Shosaku, Kanazawa Shigenori, Kuwana Midori, Muramatsu Mikiko, Yamaguchi Kazuyuki, Fukuhara Shirou

Abstract excerpt

PURPOSE: In recent years, the use of immunotherapy for malignant tumors has been proposed. To explore the significance of immunotherapy for lung cancer, we examined two systems : the HLA class I and cancer-reactive CTL system, and the Fas-FasL system. METHODS: HLA class I (HLA-A, -B, and -C) anti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8-Positive T-Lymphocytes
Share to Cytotoxicity, Immunologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fas Ligand Protein

Share to fas Receptor

Share to Histocompatibility Antigens Class I

Share to Lymphocyte Activation

Share to Microscopy, Confocal

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 12458337
DOI: 10.1007/s00432-002-0381-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12458337-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.PMID 12458337Read ↗

Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2.Semantic proximity Read ↗

HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.Semantic proximity Read ↗

Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)Semantic proximity Read ↗

Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.Semantic proximity Read ↗

Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.Semantic proximity Read ↗

Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.Semantic proximity Read ↗

Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma.Semantic proximity Read ↗

Prospects for Combined Treatment of Non-Small Cell Lung Cancer Using Autologous Activated LymphocytesSemantic proximity Read ↗

Establishment of an immortalized T-cell line from lung cancer tissue: phenotypic and functional analyses.Semantic proximity Read ↗

MHC class II expression in lung cancer.Semantic proximity Read ↗

Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer.Semantic proximity Read ↗

[Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.